Saturday, November 2, 2024

Canada’s Politics and Government News Source Since 1989

Saturday, November 2, 2024 | Latest Paper

TRENDING:

Pharmacare bill offers too much ambiguity and too little ambition

To understand and maximize value, we should know why the government chose this odd-duck model, and diabetes and contraception drugs over others. Politics over public health, perhaps?

Opinion
BY CHRIS BONNETT
April 10, 2024

Opinion | BY CHRIS BONNETT | April 10, 2024

More Opinion

Trump’s climate ignorance won’t derail global efforts

OpinionBY GWYNNE DYER

Will Susan Holt’s new government continue New Brunswick’s nuclear fantasies?

OpinionBY SUSAN O’DONNELL

Bill C-20 is a missed opportunity for real accountability

OpinionBY FAISAL KUTTY

Saving the political furniture

OpinionBY STEPHEN JEFFERY

Continued cost of inaction on breast screening guidelines is too high

OpinionBY JENNIE DALE

Related Stories

Pharmacare bill and Liberal messaging at odds, confusing stakeholders on vision for ‘single-payer’ system

NewsBY TESSIE SANCI

Next step in universal drug coverage should prioritize ‘essential medicines,’ says pharmacare expert

NewsBY JESSE CNOCKAERT

Budget’s ‘slow rollout’ pharmacare funding leaves program vulnerable to change in governments, say policy experts

NewsBY IAN CAMPBELL

Feds must expand pharmacare to include essential drugs for our deadliest diseases: cancer, heart conditions, and stroke

OpinionBY ANDREA SEALE, DOUG ROTH

Protecting public health care has never been more important

OpinionBY LIBERAL MP YASIR NAQVI